We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

19 May 2026 - 22 May 2026
17 Jun 2026 - 19 Jun 2026

Diabetes Slows Nerve Recovery After Heart Transplant

By HospiMedica staff writers
Posted on 18 Sep 2006
Diabetes has a negative effect on a patient's ability to recover from a heart transplant, noted a recent study. More...


"Using positron emission tomography [PET] and the transplanted heart as a very specific model to study the regenerative capacity of the heart's sympathetic nervous system, we determined that reinnervation--or the heart's ability to develop new nerves to replace damaged ones--is slower in diabetic patients,” said Dr. Frank M. Bengel, a visiting associate professor of radiology and the director of cardiovascular nuclear medicine from the department of radiology and radiologic science at Johns Hopkins Medicine (Baltimore, MD, USA) and co-author of the study, which was published in the September 2006 issue of the Journal of Nuclear Medicine. "Our results confirm a detrimental effect of diabetes on the potential for recovery of sympathetic nerve fibers of the heart.”

"A better understanding of the importance of nervous system abnormalities and an imaging technique to precisely characterize nerve damage may be of value to guide future therapeutic efforts aimed at reducing cardiac risk with diabetes mellitus patients,” explained Dr. Bengel, who was an associate professor at the Technical University of Munich (Germany), where the study was performed, prior to his move to Johns Hopkins. "Even if a transplant recipient is suffering from diabetes, there is still a chance for reinnervation--just at a slower speed. Unfortunately, there are no techniques developed yet that speed the nerve-regeneration process,” he said.

At present, nuclear medicine modalities (such as PET) are the only imaging techniques that can measure the presence and function of the sympathetic nervous system of the heart, according to Dr. Bengel. "There are invasive methods that allow for the measurement of neurotransmitters released to the blood, offering indirect conclusions about the presence, storage, and release of neurotransmitters from neurons. These methods require complicated and laborious sampling of blood from coronary arteries and veins,” he added.

Future studies will be needed to determined how regeneration of sympathetic nerves can be facilitated and how changes of the sympathetic nerve integrity in the heart are interrelated with changes of prognosis and outcome of diseases like diabetes mellitus, according to Dr. Bengel.



Related Links:
Johns Hopkins Medicine

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Fetal Monitor
BT-380
New
Medical-Grade Display
HL2316SHTB
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Copyright © 2000-2026 Globetech Media. All rights reserved.